FAQ
Log In
Saturday 3rd December 2016
News
 › 
 › 

Ovarian cancer therapy

15th June 2007

Research has discovered that a hormone therapy treatment used to treat breast tumours has also proved successful in tackling ovarian cancer.

The Edinburgh University study found an anti-oestrogen drug, known as Letrozole hormone therapy, could help prolong patients’ lives by up to three years and also delay the need for some to undergo chemotherapy.

Ovarian cancer affects one in 48 women, with almost 7,000 new cases in the UK every year. Professor John F Smyth, who led the study funded by Cancer Research UK, described its findings as an important landmark in the research and treatment of ovarian cancer.

 

 

Share this page

Comments

There are no comments for this article, be the first to comment!


Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2016